|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | |||||||||||
| Marketable securities | |||||||||||
| Other receivables | |||||||||||
| Prepaid expenses | |||||||||||
| Warrant derivative (notes 9, 17) | |||||||||||
| Total current assets | |||||||||||
| Property and equipment (note 6) | |||||||||||
| Right-of-use assets (note 8) | |||||||||||
| Prepaid expenses (note 5) | |||||||||||
| Total assets | |||||||||||
| Accounts payable and accrued liabilities (note 7) | |||||||||||
| Other liabilities (note 5) | |||||||||||
| Lease liabilities (note 8) | |||||||||||
| Total current liabilities | |||||||||||
| Contract liability (note 13) | |||||||||||
| Total liabilities | |||||||||||
| Share capital (note 10) Authorized: unlimited Issued: December 31, 2024 – 80,020,131 December 31, 2023 – 74,423,960 | |||||||||||
| Contributed surplus (note 11) | |||||||||||
| Accumulated other comprehensive income | |||||||||||
| Accumulated deficit | |||||||||||
| Total shareholders’ equity | |||||||||||
| ASSETS | |||||||||||
| Current assets | |||||||||||
| Cash and cash equivalents | |||||||||||
| Other receivables | |||||||||||
| Prepaid expenses | |||||||||||
| Total current assets | |||||||||||
| Property and equipment, net | |||||||||||
| Right-of-use assets | |||||||||||
| Total assets | |||||||||||
| LIABILITIES AND STOCKHOLDERS’ DEFICIT | |||||||||||
| Current liabilities | |||||||||||
| Accounts payable | |||||||||||
| Accrued liabilities | |||||||||||
| Other liabilities | |||||||||||
| Operating lease liabilities, current | |||||||||||
| Warrant derivative | |||||||||||
| Total current liabilities | |||||||||||
| Contract liability | |||||||||||
| Stock option liability | |||||||||||
| Operating lease liabilities, non-current | |||||||||||
| Total liabilities | |||||||||||
| Stockholders’ Deficit: | |||||||||||
| Common stock, par value $0.001; 1,000,000,000 authorized as of June 30, 2026. Common stock, no par value; Unlimited authorized as of December 31, 2025. 124,637,521 and 108,021,271 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively. | |||||||||||
| Additional paid-in capital | |||||||||||
| Accumulated other comprehensive income | |||||||||||
| Accumulated deficit | |||||||||||
| Total stockholders’ deficit | |||||||||||
| Total liabilities and stockholders' deficit | |||||||||||
Loading...
